Report of the PMDA-ATC Pharmaceuticals Review Webinar for JICA trainees 2022

  From July 13 to 15 and July 19, 2022, the PMDA held a four-day online seminar entitled “PMDA-ATC Pharmaceuticals Review Webinar for JICA trainees 2022”, with the Japan International Cooperation Agency (JICA). Eight people from seven countries/regions (Bhutan, Indonesia, Iraq, Laos, North Macedonia, Samoa, and Timor-Leste) participated in the webinar. Before attending the live webinar, the participants studied E-learning materials covering topics such as the overview of the PMDA, approval review in Japan, approval review of generic drugs, safety measures, GMP inspections, pharmaceutical administration in local governments, etc. In the online live webinar, participants had Q&A sessions with lecturers from the PMDA, Ministry of Health, Labour and Welfare (MHLW), and Pharmaceutical Policy Division at the Health and Welfare Department of Toyama Prefectural Government.
 

  See attached program